Deal Announcements

Nereus Pharma Accepts $20 Million New Funding

Thursday, June 24, 2010 5:53:00 AM PDT | VentureDeal Staff

San Diego, California  --  Nereus Pharmaceuticals has secured $20 million in a new round of venture capital investment.

Nereus is developing a number of anticancer agents that are currently in mid-stage clinical trials.
HBM BioVentures led the round, which also included Advent International, Forward Ventures, Alta Partners, Gimv, Roche Venture Fund and Astellas Venture Management.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1